The FSCS has ended months of uncertainty by confirming it can compensate investors with Keydata products backed by Lifemark but investors will not know the amount they will receive until the end of October.
In an update for customers holding investments in the Luxembourg-based company, the FSCS says it is satisfied the marketing materials produced by Keydata to promote the products failed to comply with FSA rules. "This means that Keydata may owe a legal liability to investors in these products, allowing us to pay compensation to anyone who is eligible under the FSCS's compensation rules," it says. The products affected by the announcement include: the Defined Income Plan issues 1-8, the Income Plan issues 1-14, the Secure Income Bond issue 4 and the Secure Income Plan 1-14. However, ...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes